{"title":"少肌症对社区中老年人骨质疏松和脆性骨折风险的影响:一项系统综述和荟萃分析","authors":"Min Cui, Kang Yu, Chun-wei Li, Fang Wang","doi":"10.3760/CMA.J.ISSN.1674-635X.2019.04.002","DOIUrl":null,"url":null,"abstract":"Objective \nTo explore the relationship between sarcopenia and the risks of osteoporosis and fragility fractures among community-dwelling middle and old people (≥50 years). \n \n \nMethods \nOVID/Medline, Pubmed, EMBASE, Cochrane Library, Web of Science (SCI), China National Knowledge Infrastructure (CNKI), and Chinese WanFang Database were searched systematically for literatures related to the relationship between sarcopenia and osteoporosis and fragility fractures from January 1987 to July 2018. The searched literatures were screened based on the inclusion and exclusion criteria. The quality of the literatures were evaluated by using the risk assessment tool NOS (Newcastle-Ottawa Scale) and AHRQ (Agency for Healthcare Research and Quality). Meta-regression analysis was used to explore the cause of heterogeneity between studies. The subgroup analysis was used to assess the differences in the risk of osteoporosis based on the important characteristic variables, such as gender, ethnicity, age, diagnostic criteria of sarcopenia, and outcome type. Sensitivity analysis and trim and fill method were conducted to test the stability of the results of this Meta-analysis. Data collected and summarized by Stata 12.2 software. \n \n \nResults \nA total of 23 studies in line with quality requirements were included eventually, including 56, 544 subjects. The results of this Meta-analysis were relatively robust. Compared with non-sarcopenia, the relative risk (RR) for osteoporosis among subjects with sarcopenia was 1.61 (95% CI: 1.42~1.82, P<0.000 01). Especially, compared with postmenopausal women RR=1.37 (95% CI: 1.23-1.53, P<0.000 1) and yellow race RR=1.53 (95% CI: 1.34-1.75, P<0.000 1), sarcopenia had a higher impact trend on the risk of osteoporosis in older men RR=2.26 (95% CI: 1.71-2.98, P<0.000 1) and Caucasian RR=2.03 (95% CI: 1.46-2.81, P<0.000 1). \n \n \nConclusion \nAmong community-dwelling middle and old aged people(≥50 year), sarcopenia increases the risk of osteoporosis and fragility fracture by 61% and 59% -61% significantly, respectively. Middle and old aged people should be prevented and screened early for sarcopenia, which attributes to identify high risk groups of fragile fractures and reduce the risk of adverse outcomes. \n \n \nKey words: \nSarcopenia; Osteoporosis; Fragility fractures; Meta-analysis","PeriodicalId":9877,"journal":{"name":"中华临床营养杂志","volume":"27 1","pages":"204-212"},"PeriodicalIF":0.0000,"publicationDate":"2019-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of sarcopenia on the risks of osteoporosis and fragility fractures among community-dwelling middle and old age people: a systematic review and meta-analysis\",\"authors\":\"Min Cui, Kang Yu, Chun-wei Li, Fang Wang\",\"doi\":\"10.3760/CMA.J.ISSN.1674-635X.2019.04.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective \\nTo explore the relationship between sarcopenia and the risks of osteoporosis and fragility fractures among community-dwelling middle and old people (≥50 years). \\n \\n \\nMethods \\nOVID/Medline, Pubmed, EMBASE, Cochrane Library, Web of Science (SCI), China National Knowledge Infrastructure (CNKI), and Chinese WanFang Database were searched systematically for literatures related to the relationship between sarcopenia and osteoporosis and fragility fractures from January 1987 to July 2018. The searched literatures were screened based on the inclusion and exclusion criteria. The quality of the literatures were evaluated by using the risk assessment tool NOS (Newcastle-Ottawa Scale) and AHRQ (Agency for Healthcare Research and Quality). Meta-regression analysis was used to explore the cause of heterogeneity between studies. The subgroup analysis was used to assess the differences in the risk of osteoporosis based on the important characteristic variables, such as gender, ethnicity, age, diagnostic criteria of sarcopenia, and outcome type. Sensitivity analysis and trim and fill method were conducted to test the stability of the results of this Meta-analysis. Data collected and summarized by Stata 12.2 software. \\n \\n \\nResults \\nA total of 23 studies in line with quality requirements were included eventually, including 56, 544 subjects. The results of this Meta-analysis were relatively robust. Compared with non-sarcopenia, the relative risk (RR) for osteoporosis among subjects with sarcopenia was 1.61 (95% CI: 1.42~1.82, P<0.000 01). Especially, compared with postmenopausal women RR=1.37 (95% CI: 1.23-1.53, P<0.000 1) and yellow race RR=1.53 (95% CI: 1.34-1.75, P<0.000 1), sarcopenia had a higher impact trend on the risk of osteoporosis in older men RR=2.26 (95% CI: 1.71-2.98, P<0.000 1) and Caucasian RR=2.03 (95% CI: 1.46-2.81, P<0.000 1). \\n \\n \\nConclusion \\nAmong community-dwelling middle and old aged people(≥50 year), sarcopenia increases the risk of osteoporosis and fragility fracture by 61% and 59% -61% significantly, respectively. Middle and old aged people should be prevented and screened early for sarcopenia, which attributes to identify high risk groups of fragile fractures and reduce the risk of adverse outcomes. \\n \\n \\nKey words: \\nSarcopenia; Osteoporosis; Fragility fractures; Meta-analysis\",\"PeriodicalId\":9877,\"journal\":{\"name\":\"中华临床营养杂志\",\"volume\":\"27 1\",\"pages\":\"204-212\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-08-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华临床营养杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1674-635X.2019.04.002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Nursing\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华临床营养杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1674-635X.2019.04.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Nursing","Score":null,"Total":0}
引用次数: 0
摘要
目的探讨社区中老年人(≥50岁)少肌症与骨质疏松和脆性骨折风险的关系。方法系统检索1987年1月至2018年7月期间,OVID/Medline、Pubmed、EMBASE、Cochrane Library、Web of Science(SCI)、中国知网(CNKI)和中国万方数据库中有关少肌症与骨质疏松和脆性骨折关系的文献。根据纳入和排除标准对检索到的文献进行筛选。使用风险评估工具NOS(Newcastle Ottawa量表)和AHRQ(Agency for Healthcare Research and quality)对文献质量进行评估。Meta回归分析用于探讨研究之间异质性的原因。亚组分析用于根据重要的特征变量,如性别、种族、年龄、少肌症的诊断标准和结果类型,评估骨质疏松症风险的差异。采用敏感性分析和修剪填充法来检验该荟萃分析结果的稳定性。Stata 12.2软件收集和汇总的数据。结果最终纳入符合质量要求的23项研究,包括56444名受试者。该荟萃分析的结果相对稳健。与非少肌症相比,少肌症受试者患骨质疏松症的相对风险(RR)为1.61(95%CI:1.42~1.82,P<0.01)。特别是,与绝经后女性RR=1.37(95%CI:1.23-1.53,P<0.0001)和黄种RR=1.53(95%CI:1.34-1.75,P<0.0001。结论在社区居住的中老年人(≥50岁)中,少肌症可使骨质疏松症和脆性骨折的风险分别显著增加61%和59%-61%。中老年人应尽早预防和筛查少肌症,这有助于识别脆弱骨折的高危人群并降低不良后果的风险。关键词:Sarcopenia;骨质疏松症;脆性骨折;Meta分析
Effects of sarcopenia on the risks of osteoporosis and fragility fractures among community-dwelling middle and old age people: a systematic review and meta-analysis
Objective
To explore the relationship between sarcopenia and the risks of osteoporosis and fragility fractures among community-dwelling middle and old people (≥50 years).
Methods
OVID/Medline, Pubmed, EMBASE, Cochrane Library, Web of Science (SCI), China National Knowledge Infrastructure (CNKI), and Chinese WanFang Database were searched systematically for literatures related to the relationship between sarcopenia and osteoporosis and fragility fractures from January 1987 to July 2018. The searched literatures were screened based on the inclusion and exclusion criteria. The quality of the literatures were evaluated by using the risk assessment tool NOS (Newcastle-Ottawa Scale) and AHRQ (Agency for Healthcare Research and Quality). Meta-regression analysis was used to explore the cause of heterogeneity between studies. The subgroup analysis was used to assess the differences in the risk of osteoporosis based on the important characteristic variables, such as gender, ethnicity, age, diagnostic criteria of sarcopenia, and outcome type. Sensitivity analysis and trim and fill method were conducted to test the stability of the results of this Meta-analysis. Data collected and summarized by Stata 12.2 software.
Results
A total of 23 studies in line with quality requirements were included eventually, including 56, 544 subjects. The results of this Meta-analysis were relatively robust. Compared with non-sarcopenia, the relative risk (RR) for osteoporosis among subjects with sarcopenia was 1.61 (95% CI: 1.42~1.82, P<0.000 01). Especially, compared with postmenopausal women RR=1.37 (95% CI: 1.23-1.53, P<0.000 1) and yellow race RR=1.53 (95% CI: 1.34-1.75, P<0.000 1), sarcopenia had a higher impact trend on the risk of osteoporosis in older men RR=2.26 (95% CI: 1.71-2.98, P<0.000 1) and Caucasian RR=2.03 (95% CI: 1.46-2.81, P<0.000 1).
Conclusion
Among community-dwelling middle and old aged people(≥50 year), sarcopenia increases the risk of osteoporosis and fragility fracture by 61% and 59% -61% significantly, respectively. Middle and old aged people should be prevented and screened early for sarcopenia, which attributes to identify high risk groups of fragile fractures and reduce the risk of adverse outcomes.
Key words:
Sarcopenia; Osteoporosis; Fragility fractures; Meta-analysis
期刊介绍:
The Chinese Journal of Clinical Nutrition was founded in 1993. It is the first professional academic journal (bimonthly) in my country co-sponsored by the Chinese Medical Association and the Chinese Academy of Medical Sciences to disseminate information on clinical nutrition support, nutrient metabolism, the impact of nutrition support on outcomes and "cost-effectiveness", as well as translational medicine and nutrition research. It is also a professional journal of the Chinese Medical Association's Parenteral and Enteral Nutrition Branch.
The purpose of the Chinese Journal of Clinical Nutrition is to promote the rapid dissemination of knowledge on nutrient metabolism and the rational application of parenteral and enteral nutrition, focusing on the combination of multidisciplinary and multi-regional field investigations and clinical research. It mainly reports on nutritional risk screening related to the indications of parenteral and enteral nutrition support, "cost-effectiveness" research on nutritional drugs, consensus on clinical nutrition, guidelines, expert reviews, randomized controlled studies, cohort studies, glycoprotein and other nutrient metabolism research, systematic evaluation of clinical research, evidence-based case reports, special reviews, case reports and clinical experience exchanges, etc., and has a special column on new technologies related to the field of clinical nutrition and their clinical applications.